GIC Private Ltd, a 10% owner of $MDLN (Medline Inc.), sold a total of 2,248,612 shares over two trading days in early August 2026, generating aggregate proceeds of $79,971,447.52 according to a Form 4 filing submitted to the Securities and Exchange Commission on August 7.
The August Transactions
The sales unfolded across three separate transactions. On August 5, the entity sold 265,711 shares at a price of $36.48 per share for gross proceeds of $9,693,137.28, then sold an additional 1,710,907 shares at $35.46 per share for $60,668,762.22. The following day, August 6, GIC sold another 271,994 shares at $35.33 per share, producing $9,609,548.02. The three trades were bundled into a single SEC filing dated August 7, one day after the final transaction.
The shares-owned-after figures on the Form 4 show the entity's reported position declining from 27,241,378 shares to 24,992,766 shares across the two-day selling window — a reduction of roughly 8.3%.
Prior Trading Activity
GIC Private Ltd last disclosed transactions in $MDLN on December 18, 2025, when it both purchased and sold shares on the same day. The December 2025 filing reported an open-market purchase of 12,586,206 shares at $29.00 per share (total: $364,999,974) alongside a sale of 10,204,351 shares at $28.37 per share (total: $289,480,090.47). The purchase left the entity with a reported position of 27,241,378 shares, which remained unchanged until the August 2026 sales.
Broader Context
The August sales followed a period of significant insider activity in $MDLN. On March 10, 2026, multiple private-equity sponsors that had taken Medline public filed seven separate Form 4s disclosing 16 sale transactions that collectively amounted to 186.3 million shares and approximately $7.6 billion in proceeds. Those filers included entities affiliated with Hellman & Friedman, Blackstone, and Carlyle Group, all reporting as 10% owners.
Medline Inc., a healthcare products manufacturer and distributor, had a market capitalization of approximately $51.6 billion at the time of the August sales. The company's stock closed at $42.04 on August 4, then declined to $36.67 on August 5 and $34.51 on August 6, alongside a significant increase in daily trading volume on both days.